enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Post-chemotherapy cognitive impairment - Wikipedia

    en.wikipedia.org/wiki/Post-chemotherapy...

    Post-chemotherapy cognitive impairment ( PCCI) (also known in the scientific community as " CRCIs or Chemotherapy-Related Cognitive Impairments " and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment.

  3. Prism correction - Wikipedia

    en.wikipedia.org/wiki/Prism_correction

    Prism dioptres. Prism correction is commonly specified in prism dioptres, a unit of angular measurement that is loosely related to the dioptre. Prism dioptres are represented by the Greek symbol delta (Δ) in superscript. A prism of power 1 Δ would produce 1 unit of displacement for an object held 100 units from the prism. [2]

  4. Metronomic therapy - Wikipedia

    en.wikipedia.org/wiki/Metronomic_therapy

    Metronomic therapy. Metronomic therapy is a new type of chemotherapy in which anti-cancer drugs are administered in a lower dose than the maximum tolerated dose repetitively over a long period to treat cancers with fewer side effects. Metronomic therapy is shown to affect both tumor microenvironment and tumor cells to achieve its therapeutic ...

  5. Isabella Strahan Shares Difficult Cancer Treatment Side Effect

    www.aol.com/isabella-strahan-shares-difficult...

    The teen has undergone three craniotomies and three rounds of chemotherapy since being diagnosed with a brain tumor last fall. Isabella Strahan Shares Difficult Cancer Treatment Side Effect Skip ...

  6. Chemotherapy - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy

    Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs ( chemotherapeutic agents or alkylating agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs) or it may ...

  7. Chemotherapy regimen - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy_regimen

    Chemotherapy regimen. A chemotherapy regimen is a regimen for chemotherapy, defining the drugs to be used, their dosage, the frequency and duration of treatments, and other considerations. In modern oncology, many regimens combine several chemotherapy drugs in combination chemotherapy. The majority of drugs used in cancer chemotherapy are ...

  8. Chemotherapy-induced peripheral neuropathy - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy-induced...

    Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve-damaging side effect of antineoplastic agents in the common cancer treatment, chemotherapy. CIPN afflicts between 30% and 40% of patients undergoing chemotherapy.

  9. Convergence insufficiency - Wikipedia

    en.wikipedia.org/wiki/Convergence_insufficiency

    Convergence insufficiency. Convergence Insufficiency. Other names. Convergence disorder. Specialty. Ophthalmology, optometry. Convergence insufficiency is a sensory and neuromuscular anomaly of the binocular vision system, characterized by a reduced ability of the eyes to turn towards each other, or sustain convergence .

  10. Chemotherapy-induced nausea and vomiting - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy-induced...

    Chemotherapy-induced nausea and vomiting ( CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most ...

  11. Chemoprotective agent - Wikipedia

    en.wikipedia.org/wiki/Chemoprotective_agent

    Each agent has different side effects though the most common consist of dizziness, sleepiness, nausea, fever, etc. [3] It is important to discuss the side effects of these drugs with a doctor before using them to combat any type of chemotherapy to insure the drug will benefit each and every patient.